Microscale bioprocessing system and method for protein manufacturing from human blood
US12227734B2 · kind B2 · utility
0Cited by
16References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2022 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Jul 16, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2202/0445
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
A bioprocessing system for protein manufacturing from human blood is provided that is compact, integrated and suited for on-demand production and delivery of therapeutic proteins to patients. The parent's own blood can be used as the source of cell extracts for the production of the therapeutic proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.